Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

Article  CAS  PubMed  Google Scholar 

Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD, et al. Drug repurposing for the treatment of glioblastoma multiforme. J Exp Clin Cancer Res. 2017;36(1):169–x.

Article  PubMed  PubMed Central  Google Scholar 

Alonso MM, Gomez-Manzano C, Bekele BN, Yung WKA, Fueyo J. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007;67(24):11499–504.

Article  CAS  PubMed  Google Scholar 

Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, et al. Temozolomide and other alkylating agents in glioblastoma therapy. Biomedicines. 2019;7(3):69. https://doi.org/10.3390/biomedicines7030069.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hegi ME, Diserens A, Gorlia T, Hamou M, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003.

Article  CAS  PubMed  Google Scholar 

Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3(3):198–210.

Article  PubMed  PubMed Central  Google Scholar 

Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res. 2008;14(10):2900–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Li Y, Yu T, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Safari M, Khoshnevisan A. Cancer stem cells and chemoresistance in glioblastoma multiform: a review article. J Stem Cells. 2015;10(4):271–85.

CAS  PubMed  Google Scholar 

Campos-Sandoval JA, Gómez-García MC, Santos-Jiménez JDL, Matés JM, Alonso FJ, Márquez J. Antioxidant responses related to temozolomide resistance in glioblastoma. Neurochem Int. 2021;149: 105136.

Article  CAS  PubMed  Google Scholar 

Cockfield JA, Schafer ZT. Antioxidant defenses: a context-specific vulnerability of cancer cells. Cancers (Basel). 2019;11(8):1208. https://doi.org/10.3390/cancers11081208.

Article  CAS  PubMed  Google Scholar 

Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature. 1966;209(5029):1248–9.

Article  CAS  PubMed  Google Scholar 

Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol. 2003;4(4):285–94.

Article  CAS  PubMed  Google Scholar 

Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, et al. Brain tumour cells interconnect to a functional and resistant network. Nature. 2015;528(7580):93–8.

Article  CAS  PubMed  Google Scholar 

Gielen PR, Aftab Q, Ma N, Chen VC, Hong X, Lozinsky S, et al. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway. Neuropharmacology. 2013;75:539–48.

Article  CAS  PubMed  Google Scholar 

Grek CL, Sheng Z, Naus CC, Sin WC, Gourdie RG, Ghatnekar GG. Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics. Curr Opin Pharmacol. 2018;41:79–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crespin S, Fromont G, Wager M, Levillain P, Cronier L, Monvoisin A, et al. Expression of a gap junction protein, connexin43, in a large panel of human gliomas: new insights. Cancer Med. 2016;5(8):1742–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cottin S, Gould PV, Cantin L, Caruso M. Gap junctions in human glioblastomas: implications for suicide gene therapy. Cancer Gene Ther. 2011;18(9):674–81.

Article  CAS  PubMed  Google Scholar 

Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, et al. Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide. Cancer Res. 2016;76(1):139–49.

Article  CAS  PubMed  Google Scholar 

Le HT, Sin WC, Lozinsky S, Bechberger J, Vega JL, Guo XQ, et al. Gap junction intercellular communication mediated by connexin43 in astrocytes is essential for their resistance to oxidative stress. J Biol Chem. 2014;289(3):1345–54.

Article  CAS  PubMed  Google Scholar 

Zhao C, Fang J, Li C, Zhang M. Connexin43 and AMPK have essential role in resistance to oxidative stress induced necrosis. Biomed Res Int. 2017;2017:3962173.

Article  PubMed  PubMed Central  Google Scholar 

Winkler F. Silencing glioblastoma networks to make temozolomide more effective. Neuro Oncol. 2021;23(11):1807–9.

Article  PubMed  PubMed Central  Google Scholar 

Wang G, Wang Y, Wang S, Zhu L. Down-regulation of CX43 expression by miR-1 inhibits the proliferation and invasion of glioma cells. Transl Cancer Res. 2022;11(11):4126–36.

Article  PubMed  PubMed Central  Google Scholar 

Che J, DePalma TJ, Sivakumar H, Mezache LS, Tallman MM, Venere M, et al. αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform. Biotechnol Bioeng. 2023;120(4):1108–19.

Article  CAS  PubMed  Google Scholar 

Mesnil M, Crespin S, Avanzo J, Zaidan-Dagli M. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta. 2005;1719(1–2):125–45.

Article  CAS  PubMed  Google Scholar 

Strale P, Clarhaut J, Lamiche C, Cronier L, Mesnil M, Defamie N. Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion. Mol Carcinog. 2012;51(11):845–60.

Article  CAS  PubMed  Google Scholar 

Lin JHC, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S, et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci. 2002;22(11):4302–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chepied A, Daoud-Omar Z, Meunier-Balandre A, Laird DW, Mesnil M, Defamie N. Involvement of the gap junction protein, Connexin43, in the formation and function of invadopodia in the human U251 glioblastoma cell line. Cells. 2020;9(1):117. https://doi.org/10.3390/cells9010117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin SY, Lee KS, Choi Y, Lim HJ, Lee HG, Lim Y, et al. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis. 2013;34(9):2080–9.

Article  CAS  PubMed